For research use only. We do not sell to patients.
WRW4 TFA
Biological Activity：WRW4 TFA, a specific formyl peptide receptor-like 1 (FPRL1) antagonist, inhibits WKYMVm binding to FPRL1 with an IC50 of 0.23 μM. WRW4 TFA specifically inhibits the increase in intracellular calcium by the FPRL1 agonists MMK-1, amyloid beta42 (Abeta42) peptide, and F peptide.
Research Area：Neurological Disease
Targets：Formyl Peptide Receptor (FPR)
Related Small Molecules:WKYMVM;BMS-986235;FPR Agonist 43;{Boc}-Phe-Leu-Phe-Leu-Phe TFA;ACT-389949;N-Formyl-Met-Leu-Phe-Lys;HCH6-1;Ac9-25;Boc-MLF TFA;N-Boc-Phe-Leu-Phe-Leu-Phe;WKYMVM-NH2 TFA;N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys;Cyclosporin H;AG-09/1
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
